Clinical development in Asia, Africa and Latin America: Streamlining the procedure for obtaining global clinical trial approvals
1st-2nd December 2008, Intercontinental Hotel, Singapore
Is the concept of the simultaneous global clinical development of new medicines becoming a reality or is it still a vision for the future?
In December 2008 the CMR International Institute for Regulatory Science (the Institute) hosted a Workshop in Singapore to discuss this goal and whether it has become more achievable since the Institute held a Workshop in Tokyo in October 2006 to address similar questions in relation to Global Drug Development: Asia’s role and contribution.
Innovative new medicines have ‘traditionally’ been developed and tested in the so-called ‘core’ countries of the ICH affiliated regions. Increasingly, however, pharmaceutical companies have been seeking new territories outside the ICH regions into which they can extend their clinical research activities.